| Product Code: ETC9978427 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Tuberculosis Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Tuberculosis Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Tuberculosis Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Tuberculosis Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 United States (US) Tuberculosis Diagnostics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 United States (US) Tuberculosis Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of tuberculosis in the United States |
4.2.2 Rising awareness about early diagnosis and treatment of tuberculosis |
4.2.3 Technological advancements in diagnostic tools for tuberculosis detection |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of tuberculosis diagnostics |
4.3.2 High cost associated with advanced tuberculosis diagnostic tests |
4.3.3 Limited access to healthcare facilities in certain regions of the United States |
5 United States (US) Tuberculosis Diagnostics Market Trends |
6 United States (US) Tuberculosis Diagnostics Market, By Types |
6.1 United States (US) Tuberculosis Diagnostics Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Radiographic Method, 2021- 2031F |
6.1.4 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Diagnostic Laboratory Methods, 2021- 2031F |
6.1.5 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Nucleic Acid Testing, 2021- 2031F |
6.1.6 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Phage Assay, 2021- 2031F |
6.1.7 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Detection of Latent Infection (Skin Test & IGRA), 2021- 2031F |
6.1.8 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Cytokine Detection Assay, 2021- 2031F |
6.2 United States (US) Tuberculosis Diagnostics Market, By End-use |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.2.3 United States (US) Tuberculosis Diagnostics Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
7 United States (US) Tuberculosis Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Tuberculosis Diagnostics Market Export to Major Countries |
7.2 United States (US) Tuberculosis Diagnostics Market Imports from Major Countries |
8 United States (US) Tuberculosis Diagnostics Market Key Performance Indicators |
8.1 Percentage increase in the adoption rate of new tuberculosis diagnostic technologies |
8.2 Average waiting time for tuberculosis test results |
8.3 Number of public health campaigns promoting tuberculosis awareness in the United States |
8.4 Rate of successful treatment outcomes for tuberculosis patients |
8.5 Percentage of healthcare facilities offering tuberculosis diagnostic services |
9 United States (US) Tuberculosis Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Tuberculosis Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 United States (US) Tuberculosis Diagnostics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 United States (US) Tuberculosis Diagnostics Market - Competitive Landscape |
10.1 United States (US) Tuberculosis Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Tuberculosis Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here